Titlebook: Bone Marrow Transplantation; Richard Champlin Book 1990 Kluwer Academic Publishers 1990 anemia.bone marrow.diseases.immunodeficiency.infec

CESS

https://doi.org/10.1007/978-1-349-17151-4stablished therapy for genetic disorders involving the progeny of both lymphoid and hematopoietic stem cells (Table 1) [3]. The purpose of this chapter is to review the current status of allogeneic bone marrow transplantation for the treatment of genetic diseases, as well as to summarize the present

只有

無(wú)動(dòng)于衷

Claire Westall,Michael Gardinerthe only curative therapy for CML. Younger recipient age and transplant in chronic phase are associated with better outcome. Some studies suggest that transplant within 1 year of diagnosis provides a greater likelihood of survival than transplant at a longer interval from diagnosis. T-lymphocyte dep

碎石頭

FLIP

Literature of an Independent Englandmoradiotherapy, in which the dose is limited by the degree of bone marrow suppression, does not increase long-term survival for most disseminated neoplasms. Bone marrow transplantation utilizes high-dose chemoradiotherapy without regard to marrow toxicity and may be the treatment of choice for these

Substance-Abuse

minaret

Cancer Treatment and Researchhttp://image.papertrans.cn/b/image/189679.jpg

spinal-stenosis

Keratectomy

Ibd810

England, Devolution, and Fictional KingdomsOver 2000 allogeneic bone marrow transplants are reported in persons with acute lymphoblastic leukemia [reviewed in 1–6]. Results depend on remission status and age and are summarized in Table 1.